Verbatim response from ChatGPT
Short answer
- Bioidentical hormones — meaning hormones molecularly identical to human hormones (estradiol, progesterone, testosterone) — can be safe and effective for treating menopausal symptoms when prescribed and monitored by a clinician using FDA‑approved products.
- “Compounded bioidentical hormone therapy” (custom mixes from compounding pharmacies) is different: it’s less regulated, has inconsistent quality/dosing, and lacks good evidence that it’s safer or more effective than standard (FDA‑approved) hormone therapy.
What doctors and major medical societies say
- North American Menopause Society (NAMS): Hormone therapy (HT) is the most effective treatment for moderate–severe hot flashes and genitourinary symptoms; use should be individualized. NAMS warns there’s no evidence that compounded BHRT is safer than conventional HT.
- Endocrine Society: Bioidentical hormones that are FDA‑approved are acceptable alternatives; they caution against custom‑compounded products because of lack of oversight and evidence.
- American College of Obstetricians and Gynecologists (ACOG): Recommends hormone therapy for symptom control when appropriate and warns patients about the unproven claims of compounded BHRT.
- U.S. Food and Drug Administration (FDA): Warns consumers that “custom‑compounded” hormone products are not reviewed for safety, effectiveness, or quality, and that marketing claims that these are “natural” and safer are unsupported.
Safety and risks — the important points
- Risks are largely the same for bioidentical hormones and conventional hormone therapy of the same hormones/dose/route: potential increased risk of blood clots (venous thromboembolism), stroke, and — with combined estrogen+progestin — increased breast cancer risk seen in some studies (Women’s Health Initiative).
- Benefits include strong reduction in vasomotor symptoms (hot flashes/night sweats) and improvement in vaginal symptoms and quality of life. There is also a “timing” effect: starting HT near menopause tends to have a more favorable cardiovascular profile than starting many years later.
- Compounded BHRT concerns: variable potency, contamination, inconsistent dosing, lack of standardized labeling and FDA review. Testing such as saliva hormone panels are not reliable for dosing decisions.
Which products are more trustworthy
- FDA‑approved medicines that are bioidentical: micronized progesterone (Prometrium), estradiol preparations (Estrace oral, Vivelle‑Dot/Climara/Alora patches, various gels/creams). These products have controlled manufacturing, labeled doses, and clinical trials.
- Be cautious about pellet therapies (brands such as BioTE or other pellet programs) and many compounded topical creams and combinations — these are commonly compounded and less well studied.
What your doctor should do (and what to ask)
- A clinician should review your medical history, screen for breast cancer risk, cardiovascular and clotting risk, and discuss benefits vs risks.
- Ask: Is this an FDA‑approved product or compounded? Why this dose/route? How will you monitor me? What are alternatives (including nonhormonal options)? Why are you recommending pellets/compounded therapy if you are?
Practical takeaways
- If you want hormone therapy for menopausal symptoms, the safest route is to use FDA‑approved formulations prescribed and monitored by a board‑certified clinician (OB‑GYN or endocrinologist experienced in menopause).
- Avoid claims that compounded BHRT is inherently safer or more “natural.” If considering compounded therapy, make sure the compounding pharmacy is accredited (USP‑verified) and understand the tradeoffs.
- If you’re concerned: get a second opinion from a menopause specialist or refer to NAMS, ACOG, Endocrine Society and FDA informational statements.
If you want, tell me your age, symptoms, medical history (blood clot history, heart disease, breast cancer, smoking), and whether someone recommended a compounded product — I can outline more specific options and questions to bring to your doctor.